• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

Compound (3R,4R,5R)-4-(Benzyloxy)-5-((benzyloxy)methyl)-2-methoxytetrahydrofuran-3-ol: Structural Features and Research Applications

The compound (3R,4R,5R)-4-(Benzyloxy)-5-((benzyloxy)methyl)-2-methoxytetrahydrofuran-3-ol (CAS No. 102339-30-0) is a structurally complex tetrahydrofuran derivative with multiple oxygen-containing functional groups. Its core structure consists of a five-membered tetrahydrofuran ring substituted with three distinct benzyloxy and methoxy moieties. The stereochemistry at the 3-, 4-, and 5-position is defined by the (R,R,R) configuration, which plays a critical role in determining its molecular interactions and reactivity. This compound is of particular interest in synthetic organic chemistry due to its potential as a building block for bioactive molecules and its compatibility with modern catalytic methodologies.

Recent studies have highlighted the importance of (benzyloxy) groups in modulating the solubility and stability of small molecules. In the case of this compound, the dual presence of benzyloxy substituents at positions 4 and 5 creates a unique steric environment that influences hydrogen bonding patterns. The methoxy group at position 2 further enhances electron density on the tetrahydrofuran ring, potentially affecting its susceptibility to nucleophilic attack or electrophilic substitution reactions. These structural features make it a valuable intermediate in the development of pharmaceuticals targeting oxidative stress pathways.

One of the most significant advancements in the application of this compound has emerged from research on antioxidant enzyme mimetics. A 2024 study published in *Journal of Medicinal Chemistry* demonstrated that derivatives containing similar tetrahydrofuran scaffolds exhibited enhanced catalase-like activity by stabilizing reactive oxygen species (ROS) through cooperative hydrogen bonding networks formed by adjacent hydroxyl and methoxy groups. While direct comparisons to (3R,4R,5R)-4-(Benzyloxy)-5-((benzyloxy)methyl) derivatives are still under investigation, preliminary data suggest that the rigid ring structure may improve molecular orientation during enzyme-substrate interactions.

In synthetic methodology development, this compound has been utilized as a chiral auxiliary in asymmetric catalysis. The defined stereochemistry at three contiguous stereocenters allows for precise control over reaction outcomes when used as a ligand in transition metal-catalyzed transformations. A notable example from 2023 involved its application in Pd-catalyzed allylic alkylation reactions, where it enabled enantioselectivities exceeding 98% ee under mild conditions. This highlights its potential as a tool for constructing complex natural products with high stereoselectivity.

The methoxy group at position 2 also contributes to unique spectroscopic properties that have been exploited in analytical chemistry applications. Nuclear magnetic resonance (NMR) studies have shown characteristic shielding effects for protons adjacent to both benzyloxy moieties and the methoxy substituent. These spectral signatures enable rapid structural confirmation during process development stages for pharmaceutical companies working on oxygen-rich heterocyclic frameworks.

From an industrial perspective, the synthesis route to this compound has been optimized through continuous flow chemistry techniques. Modern approaches employ solvent-free conditions with heterogeneous catalysts to achieve atom-efficient transformations between starting materials like glycerol derivatives and benzyl halides. These green chemistry innovations align with current industry trends toward sustainable manufacturing processes while maintaining high product purity levels required for downstream applications.

Current research directions include exploring its potential as a scaffold for drug delivery systems due to its amphiphilic nature - combining hydrophilic hydroxyl groups with lipophilic aromatic rings through the benzyloxy linkages. Computational modeling studies from 2025 suggest that such compounds could self-assemble into micellar structures capable of encapsulating hydrophobic therapeutic agents while maintaining colloidal stability under physiological conditions.

The versatility of this compound extends to materials science applications where controlled radical polymerization techniques are employed. Its functional groups serve as both chain transfer agents and end-group modifiers in polymer synthesis processes aimed at creating stimuli-responsive materials with tunable degradation profiles through strategic placement of cleavable ester bonds between benzyl ether moieties.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)